Purpose The purpose of this study was to examine why Norway has the highest rate of
mortality due to cutaneous melanoma (CM) in Europe. The Norwegian Malignant Melanoma …

Cutaneous malignant melanoma (CMM) incidence is increasing globally, making a thorough
understanding of the disease and its outcomes essential for optimizing care even more …

BACKGROUND Cutaneous melanoma (CM) incidence and mortality have risen dramatically
during the past 2 generations, particularly among Caucasian populations. Detailed, long …

Background Melanoma incidence and mortality in Europe are high but there are significant
gaps in the epidemiological information available across the continent. Objectives With the …

The steep increase in incidence of cutaneous malignant melanoma in white populations
mainly applies to thin lesions with good survival suggesting overdiagnosis. Based on …

Background Malignant melanoma (MM) causes the highest absolute number of deaths
among skin cancers. An up‐to‐date analysis of international MM mortality trends is required …

Background Both patient survival and the proportion of patients diagnosed with thin
cutaneous malignant melanoma (CMM) have been steadily rising in Sweden as in most …

Background Incidence rates of cutaneous malignant melanoma (CMM) have been
increasing markedly worldwide. The ongoing debate about possible overdiagnosis remains …

Background Melanoma of the skin is the most dangerous skin cancer in the world, though
the numbers of reported new cases and melanoma-related deaths are low. Objective This …

Background It has been debated that the epidemic of melanoma is largely due to
overdiagnosis, since increases in incidence were mainly among thin melanomas and …